Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2011 (2011), Article ID 515047, 4 pages
http://dx.doi.org/10.4061/2011/515047
Research Article

Arginase Inhibitor in the Pharmacological Correction of Endothelial Dysfunction

1Department of Pharmacology and Pharmaceutical Sciences, Belgorod State University, 85 Pobeda Street, Belgorod 308015, Russia
2Research Institute of Ecological Medicine, Kursk State Medical University, 3 Karl Marx Street, Kursk 305041, Russia
3Department of Pharmacology, Kursk State Medical University, 3 Karl Marx Street, Kursk 305041, Russia

Received 15 February 2011; Accepted 25 April 2011

Academic Editor: Zafar Israili

Copyright © 2011 Mihail V. Pokrovskiy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [5 citations]

The following is the list of published articles that have cited the current article.

  • Shanthi Nagagarajan, Fengtian Xue, and Alexander D. MacKerell, “Impact of Substrate Protonation and Tautomerization States on Interactions with the Active Site of Arginase I,” Journal Of Chemical Information And Modeling, vol. 53, no. 2, pp. 452–460, 2013. View at Publisher · View at Google Scholar
  • Felix Quitter, Hans R. Figulla, Markus Ferrari, John Pernow, and Christian Jung, “Increased arginase levels in heart failure represent a therapeutic target to rescue microvascular perfusion,” Clinical Hemorheology and Microcirculation, vol. 54, no. 1, pp. 75–85, 2013. View at Publisher · View at Google Scholar
  • S. Uslu, E. Ozcelik, N. Kebapci, H. E. Temel, F. Demirci, B. Ergun, and C. Demirustu, “Effects of serum uric acid levels on the arginase pathway in women with metabolic syndrome,” Irish Journal of Medical Science (1971 -), 2015. View at Publisher · View at Google Scholar
  • Khaled S. Abdelkawy, Kelsey Lack, and Fawzy Elbarbry, “Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors,” European Journal of Drug Metabolism and Pharmacokinetics, 2016. View at Publisher · View at Google Scholar
  • M. V. Pokrovskii, M. V. Korokin, K. V. Kudryavtsev, T. G. Pokrovskaya, O. S. Gudyrev, V. V. Gureev, L. V. Korokina, and S. V. Povetkin, “Study of Endothelial Protective Activity of Phenol-Derived Thrombin and Arginase-2 Inhibitors KUD-259 and KUD-974,” Bulletin of Experimental Biology and Medicine, 2017. View at Publisher · View at Google Scholar